480 related articles for article (PubMed ID: 26292963)
61. Histone Deacetylase 5 Is Overexpressed in Scleroderma Endothelial Cells and Impairs Angiogenesis via Repression of Proangiogenic Factors.
Tsou PS; Wren JD; Amin MA; Schiopu E; Fox DA; Khanna D; Sawalha AH
Arthritis Rheumatol; 2016 Dec; 68(12):2975-2985. PubMed ID: 27482699
[TBL] [Abstract][Full Text] [Related]
62. Elevated vascular endothelial growth factor in systemic sclerosis.
Choi JJ; Min DJ; Cho ML; Min SY; Kim SJ; Lee SS; Park KS; Seo YI; Kim WU; Park SH; Cho CS
J Rheumatol; 2003 Jul; 30(7):1529-33. PubMed ID: 12858453
[TBL] [Abstract][Full Text] [Related]
63. Semaphorin 3E-Plexin-D1 signaling controls pathway-specific synapse formation in the striatum.
Ding JB; Oh WJ; Sabatini BL; Gu C
Nat Neurosci; 2011 Dec; 15(2):215-23. PubMed ID: 22179111
[TBL] [Abstract][Full Text] [Related]
64. Angiogenic and angiostatic factors in systemic sclerosis: increased levels of vascular endothelial growth factor are a feature of the earliest disease stages and are associated with the absence of fingertip ulcers.
Distler O; Del Rosso A; Giacomelli R; Cipriani P; Conforti ML; Guiducci S; Gay RE; Michel BA; Brühlmann P; Müller-Ladner U; Gay S; Matucci-Cerinic M
Arthritis Res; 2002; 4(6):R11. PubMed ID: 12453314
[TBL] [Abstract][Full Text] [Related]
65. Semaphorin-plexin signalling genes associated with human breast tumourigenesis.
Gabrovska PN; Smith RA; Tiang T; Weinstein SR; Haupt LM; Griffiths LR
Gene; 2011 Dec; 489(2):63-9. PubMed ID: 21925246
[TBL] [Abstract][Full Text] [Related]
66. Microvascular abnormalities in patients with early systemic sclerosis: less severe morphological changes than in patients with definite disease.
Camargo CZ; Sekiyama JY; Arismendi MI; Kayser C
Scand J Rheumatol; 2015; 44(1):48-55. PubMed ID: 25379977
[TBL] [Abstract][Full Text] [Related]
67. Angiogenesis in systemic sclerosis: impaired expression of vascular endothelial growth factor receptor 1 in endothelial progenitor-derived cells under hypoxic conditions.
Avouac J; Wipff J; Goldman O; Ruiz B; Couraud PO; Chiocchia G; Kahan A; Boileau C; Uzan G; Allanore Y
Arthritis Rheum; 2008 Nov; 58(11):3550-61. PubMed ID: 18975312
[TBL] [Abstract][Full Text] [Related]
68. Nailfold videocapillaroscopic patterns and serum autoantibodies in systemic sclerosis.
Cutolo M; Pizzorni C; Tuccio M; Burroni A; Craviotto C; Basso M; Seriolo B; Sulli A
Rheumatology (Oxford); 2004 Jun; 43(6):719-26. PubMed ID: 15026581
[TBL] [Abstract][Full Text] [Related]
69. Maximum blood flow and microvascular regulatory responses in systemic sclerosis.
Gunawardena H; Harris ND; Carmichael C; McHugh NJ
Rheumatology (Oxford); 2007 Jul; 46(7):1079-82. PubMed ID: 17494087
[TBL] [Abstract][Full Text] [Related]
70. Tumour growth inhibition and anti-metastatic activity of a mutated furin-resistant Semaphorin 3E isoform.
Casazza A; Kigel B; Maione F; Capparuccia L; Kessler O; Giraudo E; Mazzone M; Neufeld G; Tamagnone L
EMBO Mol Med; 2012 Mar; 4(3):234-50. PubMed ID: 22247010
[TBL] [Abstract][Full Text] [Related]
71. Serum levels of soluble vascular endothelial growth factor receptor-2 in patients with systemic sclerosis.
Jinnin M; Makino T; Kajihara I; Honda N; Makino K; Ogata A; Ihn H
Br J Dermatol; 2010 Apr; 162(4):751-8. PubMed ID: 19886888
[TBL] [Abstract][Full Text] [Related]
72. Enhanced expression of semaphorin 3E is involved in the gastric cancer development.
Maejima R; Tamai K; Shiroki T; Yokoyama M; Shibuya R; Nakamura M; Yamaguchi K; Abue M; Oikawa T; Noguchi T; Miura K; Fujiya T; Sato I; Iijima K; Shimosegawa T; Tanaka N; Satoh K
Int J Oncol; 2016 Sep; 49(3):887-94. PubMed ID: 27572291
[TBL] [Abstract][Full Text] [Related]
73. Brachial artery endothelial-dependent flow-mediated dilation identifies early-stage endothelial dysfunction in systemic sclerosis and correlates with nailfold microvascular impairment.
Rollando D; Bezante GP; Sulli A; Balbi M; Panico N; Pizzorni C; Negrini S; Brunelli C; Barsotti A; Cutolo M; Indiveri F; Ghio M
J Rheumatol; 2010 Jun; 37(6):1168-73. PubMed ID: 20436078
[TBL] [Abstract][Full Text] [Related]
74. Correlation of biomarkers of endothelium dysfunction and matrix remodeling in patients with systemic sclerosis.
Blaise S; Maas R; Trocme C; Kom GD; Roustit M; Carpentier PH; Cracowski JL
J Rheumatol; 2009 May; 36(5):984-8. PubMed ID: 19332631
[TBL] [Abstract][Full Text] [Related]
75. Fli1 deficiency contributes to the downregulation of endothelial protein C receptor in systemic sclerosis: a possible role in prothrombotic conditions.
Saigusa R; Asano Y; Yamashita T; Taniguchi T; Takahashi T; Ichimura Y; Toyama T; Yoshizaki A; Miyagaki T; Sugaya M; Sato S
Br J Dermatol; 2016 Feb; 174(2):338-47. PubMed ID: 26399195
[TBL] [Abstract][Full Text] [Related]
76. An Electrical Impedance-Based Method for Quantitative Real-Time Analysis of Semaphorin-Elicited Endothelial Cell Collapse.
Camillo C; Gioelli N; Bussolino F; Serini G
Methods Mol Biol; 2017; 1493():195-207. PubMed ID: 27787852
[TBL] [Abstract][Full Text] [Related]
77. Parasympathetic activity increases with digital microvascular damage and vascular endothelial growth factor in systemic sclerosis.
Gigante A; Margiotta D; Navarini L; Liberatori M; Barbano B; Tubani L; Afeltra A; Rosato E
Clin Exp Rheumatol; 2018; 36 Suppl 113(4):24-27. PubMed ID: 29787366
[TBL] [Abstract][Full Text] [Related]
78. Sema3E/plexin-D1 mediated epithelial-to-mesenchymal transition in ovarian endometrioid cancer.
Tseng CH; Murray KD; Jou MF; Hsu SM; Cheng HJ; Huang PH
PLoS One; 2011 Apr; 6(4):e19396. PubMed ID: 21559368
[TBL] [Abstract][Full Text] [Related]
79. Semaphorin 3E suppresses tumor cell death triggered by the plexin D1 dependence receptor in metastatic breast cancers.
Luchino J; Hocine M; Amoureux MC; Gibert B; Bernet A; Royet A; Treilleux I; Lécine P; Borg JP; Mehlen P; Chauvet S; Mann F
Cancer Cell; 2013 Nov; 24(5):673-85. PubMed ID: 24139859
[TBL] [Abstract][Full Text] [Related]
80. Endothelial Dysfunction and Nailfold Videocapillaroscopy Pattern as Predictors of Digital Ulcers in Systemic Sclerosis: a Cohort Study and Review of the Literature.
Silva I; Teixeira A; Oliveira J; Almeida I; Almeida R; Águas A; Vasconcelos C
Clin Rev Allergy Immunol; 2015 Oct; 49(2):240-52. PubMed ID: 26142066
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]